Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine

  • Takashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, Suguru Mizuno, Keisuke Yamamoto, Hiroshi Yagioka, Yoko Yashima, Kazumichi Kawakubo, Hirofumi Kogure, Osamu Togawa, Saburo Matsubara, Yukiko Ito, Naoki Sasahira, Kenji Hirano, Takeshi Tsujino, Nobuo Toda, Minoru Tada, Masao Omata, Kazuhiko Koike
  • Investigational New Drugs, October 2010, Springer Science + Business Media
  • DOI: 10.1007/s10637-010-9553-9

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s10637-010-9553-9

The following have contributed to this page: Dr Yousuke Nakai